Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 114

1.

Incorporation, intracellular trafficking and processing of extracellular heparanase by mast cells: Involvement of syndecan-4-dependent pathway.

Higashi N, Waki M, Sudo Y, Suzuki S, Oku T, Tsuiji M, Tsuji T, Miyagishi M, Takahashi K, Nakajima M, Irimura T.

Biochem Biophys Res Commun. 2018 Sep 18;503(4):3235-3241. doi: 10.1016/j.bbrc.2018.08.132. Epub 2018 Aug 24.

PMID:
30149916
2.

Transcription Factor YY1 Promotes Cell Proliferation by Directly Activating the Pentose Phosphate Pathway.

Wu S, Wang H, Li Y, Xie Y, Huang C, Zhao H, Miyagishi M, Kasim V.

Cancer Res. 2018 Aug 15;78(16):4549-4562. doi: 10.1158/0008-5472.CAN-17-4047. Epub 2018 Jun 19.

PMID:
29921695
3.

Elevating VEGF-A and PDGF-BB secretion by salidroside enhances neoangiogenesis in diabetic hind-limb ischemia.

Ariyanti AD, Sisjayawan J, Zhang J, Zhang JQ, Wang GX, Miyagishi M, Wu SR, Kasim V.

Oncotarget. 2017 Oct 13;8(57):97187-97205. doi: 10.18632/oncotarget.21907. eCollection 2017 Nov 14.

4.

Identification of XBP1-u as a novel regulator of the MDM2/p53 axis using an shRNA library.

Huang C, Wu S, Ji H, Yan X, Xie Y, Murai S, Zhao H, Miyagishi M, Kasim V.

Sci Adv. 2017 Oct 18;3(10):e1701383. doi: 10.1126/sciadv.1701383. eCollection 2017 Oct.

5.

Transcription factor Yin Yang 2 is a novel regulator of the p53/p21 axis.

Kasim V, Xie YD, Wang HM, Huang C, Yan XS, Nian WQ, Zheng XD, Miyagishi M, Wu SR.

Oncotarget. 2017 May 19;8(33):54694-54707. doi: 10.18632/oncotarget.18005. eCollection 2017 Aug 15.

6.

Biochemical and structural features of extracellular vesicle-binding RNA aptamers.

Murakami K, Zhao J, Yamasaki K, Miyagishi M.

Biomed Rep. 2017 Jun;6(6):615-626. doi: 10.3892/br.2017.899. Epub 2017 May 3.

7.

Inhibition of PHD3 by salidroside promotes neovascularization through cell-cell communications mediated by muscle-secreted angiogenic factors.

Zhang J, Kasim V, Xie YD, Huang C, Sisjayawan J, Dwi Ariyanti A, Yan XS, Wu XY, Liu CP, Yang L, Miyagishi M, Wu SR.

Sci Rep. 2017 Mar 7;7:43935. doi: 10.1038/srep43935.

8.

The ASK family kinases differentially mediate induction of type I interferon and apoptosis during the antiviral response.

Okazaki T, Higuchi M, Takeda K, Iwatsuki-Horimoto K, Kiso M, Miyagishi M, Yanai H, Kato A, Yoneyama M, Fujita T, Taniguchi T, Kawaoka Y, Ichijo H, Gotoh Y.

Sci Signal. 2015 Aug 4;8(388):ra78. doi: 10.1126/scisignal.aab1883. Erratum in: Sci Signal. 2017 May 30;10 (481):.

PMID:
26243192
9.

Analysis of ATP and AMP binding to a DNA aptamer and its imidazole-tethered derivatives by surface plasmon resonance.

Zhao J, Katsube S, Yamamoto J, Yamasaki K, Miyagishi M, Iwai S.

Analyst. 2015 Sep 7;140(17):5881-4. doi: 10.1039/c5an01347j. Epub 2015 Jul 29.

PMID:
26221631
10.
11.
12.

Synergistic cooperation of MDM2 and E2F1 contributes to TAp73 transcriptional activity.

Kasim V, Huang C, Zhang J, Jia H, Wang Y, Yang L, Miyagishi M, Wu S.

Biochem Biophys Res Commun. 2014 Jul 4;449(3):319-26. doi: 10.1016/j.bbrc.2014.05.026. Epub 2014 May 15.

PMID:
24845566
13.

Type II Fp of human mitochondrial respiratory complex II and its role in adaptation to hypoxia and nutrition-deprived conditions.

Sakai C, Tomitsuka E, Miyagishi M, Harada S, Kita K.

Mitochondrion. 2013 Nov;13(6):602-9. doi: 10.1016/j.mito.2013.08.009. Epub 2013 Sep 2.

PMID:
24008124
14.

Altered phospholipid molecular species and glycolipid composition in brain, liver and fibroblasts of Zellweger syndrome.

Miyazaki C, Saitoh M, Itoh M, Yamashita S, Miyagishi M, Takashima S, Moser AB, Iwamori M, Mizuguchi M.

Neurosci Lett. 2013 Sep 27;552:71-5. doi: 10.1016/j.neulet.2013.07.045. Epub 2013 Aug 7.

PMID:
23933200
15.

Determination of the role of DDX3 a factor involved in mammalian RNAi pathway using an shRNA-expression library.

Kasim V, Wu S, Taira K, Miyagishi M.

PLoS One. 2013;8(3):e59445. doi: 10.1371/journal.pone.0059445. Epub 2013 Mar 19.

16.

Transcription factor YY1 contributes to tumor growth by stabilizing hypoxia factor HIF-1α in a p53-independent manner.

Wu S, Kasim V, Kano MR, Tanaka S, Ohba S, Miura Y, Miyata K, Liu X, Matsuhashi A, Chung UI, Yang L, Kataoka K, Nishiyama N, Miyagishi M.

Cancer Res. 2013 Mar 15;73(6):1787-99. doi: 10.1158/0008-5472.CAN-12-0366. Epub 2013 Jan 17.

17.

Enhanced cancer immunotherapy using STAT3-depleted dendritic cells with high Th1-inducing ability and resistance to cancer cell-derived inhibitory factors.

Iwata-Kajihara T, Sumimoto H, Kawamura N, Ueda R, Takahashi T, Mizuguchi H, Miyagishi M, Takeda K, Kawakami Y.

J Immunol. 2011 Jul 1;187(1):27-36. doi: 10.4049/jimmunol.1002067. Epub 2011 Jun 1.

18.

Histone demethylase JMJD2B functions as a co-factor of estrogen receptor in breast cancer proliferation and mammary gland development.

Kawazu M, Saso K, Tong KI, McQuire T, Goto K, Son DO, Wakeham A, Miyagishi M, Mak TW, Okada H.

PLoS One. 2011 Mar 18;6(3):e17830. doi: 10.1371/journal.pone.0017830.

19.

Simultaneous suppression of MITF and BRAF V600E enhanced inhibition of melanoma cell proliferation.

Kido K, Sumimoto H, Asada S, Okada SM, Yaguchi T, Kawamura N, Miyagishi M, Saida T, Kawakami Y.

Cancer Sci. 2009 Oct;100(10):1863-9. doi: 10.1111/j.1349-7006.2009.01266.x. Epub 2009 Jun 29.

20.

Confirmation of multiple risk Loci and genetic impacts by a genome-wide association study of type 2 diabetes in the Japanese population.

Takeuchi F, Serizawa M, Yamamoto K, Fujisawa T, Nakashima E, Ohnaka K, Ikegami H, Sugiyama T, Katsuya T, Miyagishi M, Nakashima N, Nawata H, Nakamura J, Kono S, Takayanagi R, Kato N.

Diabetes. 2009 Jul;58(7):1690-9. doi: 10.2337/db08-1494. Epub 2009 Apr 28.

21.

Mitogen-activated protein 3 kinase 6 mediates angiogenic and tumorigenic effects via vascular endothelial growth factor expression.

Eto N, Miyagishi M, Inagi R, Fujita T, Nangaku M.

Am J Pathol. 2009 Apr;174(4):1553-63. doi: 10.2353/ajpath.2009.080190. Epub 2009 Feb 26.

22.

Effect of asymmetric terminal structures of short RNA duplexes on the RNA interference activity and strand selection.

Sano M, Sierant M, Miyagishi M, Nakanishi M, Takagi Y, Sutou S.

Nucleic Acids Res. 2008 Oct;36(18):5812-21. doi: 10.1093/nar/gkn584. Epub 2008 Sep 9.

23.

RNAi-mediated silencing of p190Bcr-Abl inactivates Stat5 and cooperates with imatinib mesylate and 17-allylamino-17-demetoxygeldanamycin in selective killing of p190Bcr-Abl-expressing leukemia cells.

Futami M, Hatano T, Soda Y, Kobayashi S, Miyagishi M, Tojo A.

Leukemia. 2008 Jun;22(6):1131-8. doi: 10.1038/leu.2008.60. Epub 2008 Mar 27.

PMID:
18368071
24.

An excellent monitoring system for surface ubiquitination-induced internalization in mammals.

Goto E, Mito-Yoshida M, Uematsu M, Aoki M, Matsuki Y, Ohmura-Hoshino M, Hotta H, Miyagishi M, Ishido S.

PLoS One. 2008 Jan 30;3(1):e1490. doi: 10.1371/journal.pone.0001490.

25.

Cooperative regulation of p73 promoter by Yin Yang 1 and E2F1.

Wu S, Murai S, Kataoka K, Miyagishi M.

Nucleic Acids Symp Ser (Oxf). 2007;(51):347-8.

PMID:
18029729
26.

Yin Yang 1 induces transcriptional activity of p73 through cooperation with E2F1.

Wu S, Murai S, Kataoka K, Miyagishi M.

Biochem Biophys Res Commun. 2008 Jan 4;365(1):75-81. Epub 2007 Nov 1.

PMID:
17980704
27.

Knockdown of the bovine prion gene PRNP by RNA interference (RNAi) technology.

Sutou S, Kunishi M, Kudo T, Wongsrikeao P, Miyagishi M, Otoi T.

BMC Biotechnol. 2007 Jul 26;7:44.

28.

DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response.

Takaoka A, Wang Z, Choi MK, Yanai H, Negishi H, Ban T, Lu Y, Miyagishi M, Kodama T, Honda K, Ohba Y, Taniguchi T.

Nature. 2007 Jul 26;448(7152):501-5. Epub 2007 Jul 8.

PMID:
17618271
29.

Genome-wide sreening by using small-interfering RNA expression libraries.

Matsumoto S, Miyagishi M, Taira K.

Methods Mol Biol. 2007;360:131-42.

PMID:
17172728
30.

Chemistry-based RNA technologies: demonstration of usefulness of libraries of ribozymes and short hairpin RNAs (shRNAs).

Miyagishi M, Matsumoto S, Akashi H, Kawasaki H, Fukao T, Fukuda Y, Sano M, Kato Y, Takagi Y, Tanaka Y, Warashina M, Kuwabara T, Sawata SY, Ikeda Y, Kawahara S, Sunil KC, Wadhwa R, Taira K.

Nucleic Acids Symp Ser (Oxf). 2005;(49):91-2.

PMID:
17150648
31.

Differentiation stage-specific analysis of gene function with inducible short hair-pin RNA in differentiating embryonic stem cells.

Hiraoka-Kanie M, Miyagishi M, Yamashita JK.

Biochem Biophys Res Commun. 2006 Dec 22;351(3):669-74. Epub 2006 Nov 3.

PMID:
17084387
32.

Escape from the interferon response associated with RNA interference using vectors that encode long modified hairpin-RNA.

Akashi H, Miyagishi M, Yokota T, Watanabe T, Hino T, Nishina K, Kohara M, Taira K.

Mol Biosyst. 2005 Dec;1(5-6):382-90. Epub 2005 Nov 7.

PMID:
16881007
33.

DeltaEF1 mediates TGF-beta signaling in vascular smooth muscle cell differentiation.

Nishimura G, Manabe I, Tsushima K, Fujiu K, Oishi Y, Imai Y, Maemura K, Miyagishi M, Higashi Y, Kondoh H, Nagai R.

Dev Cell. 2006 Jul;11(1):93-104.

34.

Myosin motor Myo1c and its receptor NEMO/IKK-gamma promote TNF-alpha-induced serine307 phosphorylation of IRS-1.

Nakamori Y, Emoto M, Fukuda N, Taguchi A, Okuya S, Tajiri M, Miyagishi M, Taira K, Wada Y, Tanizawa Y.

J Cell Biol. 2006 Jun 5;173(5):665-71.

35.

Cutting Edge: Lentiviral short hairpin RNA silencing of PTEN in human mast cells reveals constitutive signals that promote cytokine secretion and cell survival.

Furumoto Y, Brooks S, Olivera A, Takagi Y, Miyagishi M, Taira K, Casellas R, Beaven MA, Gilfillan AM, Rivera J.

J Immunol. 2006 May 1;176(9):5167-71.

36.

Down-regulation of endogenous Wt1 expression by Sry transgene in the murine embryonic mesonephros-derived M15 cell line.

Ito M, Miyagishi M, Murata C, Kawasaki H, Baba T, Tachi C, Taira K.

J Reprod Dev. 2006 Jun;52(3):415-27. Epub 2006 Mar 27.

37.

Screening of siRNA target sequences by using fragmentized DNA.

Kasim V, Taira K, Miyagishi M.

J Gene Med. 2006 Jun;8(6):782-91.

PMID:
16532512
38.

Intracellular-diced dsRNA has enhanced efficacy for silencing HCV RNA and overcomes variation in the viral genotype.

Watanabe T, Sudoh M, Miyagishi M, Akashi H, Arai M, Inoue K, Taira K, Yoshiba M, Kohara M.

Gene Ther. 2006 Jun;13(11):883-92.

PMID:
16496015
39.
40.

TRAIL-induced cell death cooperates with IFN-gamma activation in the graft-versus-tumor effect against colon tumors.

Tateishi K, Ohta M, Guleng B, Kanai F, Tanaka Y, Asaoka Y, Jazag A, Imamura J, Imamura T, Ijichi H, Ikenoue T, Kawakami T, Fukushima Y, Washida M, Sata M, Miyagishi M, Taira K, Yoshida H, Kawabe T, Omata M.

Int J Cancer. 2006 May 1;118(9):2237-46.

41.

p53-Independent negative regulation of p21/cyclin-dependent kinase-interacting protein 1 by the sonic hedgehog-glioma-associated oncogene 1 pathway in gastric carcinoma cells.

Ohta M, Tateishi K, Kanai F, Watabe H, Kondo S, Guleng B, Tanaka Y, Asaoka Y, Jazag A, Imamura J, Ijichi H, Ikenoue T, Sata M, Miyagishi M, Taira K, Tada M, Kawabe T, Omata M.

Cancer Res. 2005 Dec 1;65(23):10822-9.

42.

Defective repair of radiation-induced DNA damage is complemented by a CHORI-230-65K18 BAC clone on rat chromosome 4.

Tsuji AB, Sugyo A, Sudo H, Sagara M, Ishikawa A, Ohtsuki M, Kimura T, Ogiu T, Miyagishi M, Taira K, Imai T, Harada YN.

Genomics. 2006 Feb;87(2):236-42. Epub 2005 Nov 23.

43.

BRAF mediates RET/PTC-induced mitogen-activated protein kinase activation in thyroid cells: functional support for requirement of the RET/PTC-RAS-BRAF pathway in papillary thyroid carcinogenesis.

Mitsutake N, Miyagishi M, Mitsutake S, Akeno N, Mesa C Jr, Knauf JA, Zhang L, Taira K, Fagin JA.

Endocrinology. 2006 Feb;147(2):1014-9. Epub 2005 Oct 27.

PMID:
16254036
44.

Cancer-derived VEGF plays no role in malignant ascites formation in the mouse.

Guleng B, Tateishi K, Kanai F, Jazag A, Ohta M, Asaoka Y, Ijichi H, Tanaka Y, Imamura J, Ikenoue T, Fukushima Y, Morikane K, Miyagishi M, Taira K, Kawabe T, Omata M.

World J Gastroenterol. 2005 Sep 21;11(35):5455-9.

45.

Transgenic small interfering RNA halts amyotrophic lateral sclerosis in a mouse model.

Saito Y, Yokota T, Mitani T, Ito K, Anzai M, Miyagishi M, Taira K, Mizusawa H.

J Biol Chem. 2005 Dec 30;280(52):42826-30. Epub 2005 Oct 12.

46.

Correlation between mRNA expression of Th1/Th2 cytokines and their specific transcription factors in human helper T-cell clones.

Kitamura N, Kaminuma O, Mori A, Hashimoto T, Kitamura F, Miyagishi M, Taira K, Miyatake S.

Immunol Cell Biol. 2005 Oct;83(5):536-41.

PMID:
16174104
47.

Genome-wide application of RNAi to the discovery of potential drug targets.

Ito M, Kawano K, Miyagishi M, Taira K.

FEBS Lett. 2005 Oct 31;579(26):5988-95. Epub 2005 Aug 22. Review.

48.

Shared and unique functions of the DExD/H-box helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity.

Yoneyama M, Kikuchi M, Matsumoto K, Imaizumi T, Miyagishi M, Taira K, Foy E, Loo YM, Gale M Jr, Akira S, Yonehara S, Kato A, Fujita T.

J Immunol. 2005 Sep 1;175(5):2851-8.

49.

Single small-interfering RNA expression vector for silencing multiple transforming growth factor-beta pathway components.

Jazag A, Kanai F, Ijichi H, Tateishi K, Ikenoue T, Tanaka Y, Ohta M, Imamura J, Guleng B, Asaoka Y, Kawabe T, Miyagishi M, Taira K, Omata M.

Nucleic Acids Res. 2005 Aug 19;33(15):e131.

50.

Small interfering RNA expression vector targeting hypoxia-inducible factor 1 alpha inhibits tumor growth in hepatobiliary and pancreatic cancers.

Mizuno T, Nagao M, Yamada Y, Narikiyo M, Ueno M, Miyagishi M, Taira K, Nakajima Y.

Cancer Gene Ther. 2006 Feb;13(2):131-40.

PMID:
16096651

Supplemental Content

Loading ...
Support Center